Windtree Therapeutics Inc
NASDAQ:WINT 10:21:35 AM EDT
Earnings Announcements
Windtree Therapeutics Reports Q4 Results
Published: 03/31/2022 12:36 GMT
Windtree Therapeutics Inc (WINT) - Reported Qtrly Net Loss of $0.46 per Basic Share.
Revenue is expected to be $0.3 Million
Adjusted EPS is expected to be -$0.19
Next Quarter Revenue Guidance is expected to be $0.5 Million
Next Quarter EPS Guidance is expected to be -$0.19
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.19
Next Quarter Revenue Guidance is expected to be $0.5 Million
Next Quarter EPS Guidance is expected to be -$0.19
More details on our Analysts Page.